HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
3-(4-fluorobenzoyloxy)tropane
a local anesthetic; structure in first source
Also Known As:
3-pseudotropyl 4-fluorobenzoate; 3beta-(4-fluorobenzoyloxy)tropane; 3beta-FBT; fluorotropacocaine
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Aza Compounds: 3
Azabicyclo Compounds
Tropanes: 1
Cocaine: 10317
3-(4-fluorobenzoyloxy)tropane: 1
Heterocyclic Compounds: 198
Alkaloids: 5398
Tropanes: 1
Cocaine: 10317
3-(4-fluorobenzoyloxy)tropane: 1
Bridged-Ring Heterocyclic Compounds
Tropanes: 1
Cocaine: 10317
3-(4-fluorobenzoyloxy)tropane: 1
Heterocyclic Bridged Bicyclo Compounds
Azabicyclo Compounds
Tropanes: 1
Cocaine: 10317
3-(4-fluorobenzoyloxy)tropane: 1
Experts
1.
Dargan, Paul I
: 1 article (09/2012)
2.
Wood, David M
: 1 article (09/2012)
Related Diseases
1.
Tachycardia (Tachyarrhythmias)
09/01/2012 - "
Reports of 49 enquiries relating to a 'legal high' product called 'Whack' (which on analysis was found to contain 2-DPMP and fluorotropacocaine) commonly described unwanted cardiovascular (hypertension in 10/49 and tachycardia in 12/49) and neuropsychiatric (agitation in 14/49 and psychosis in 13/49) effects; the neuropsychiatric effects were prolonged, and persisted for up to 5 days.
"
2.
Psychotic Disorders (Schizoaffective Disorder)
09/01/2012 - "
Reports of 49 enquiries relating to a 'legal high' product called 'Whack' (which on analysis was found to contain 2-DPMP and fluorotropacocaine) commonly described unwanted cardiovascular (hypertension in 10/49 and tachycardia in 12/49) and neuropsychiatric (agitation in 14/49 and psychosis in 13/49) effects; the neuropsychiatric effects were prolonged, and persisted for up to 5 days.
"
3.
Hypertension (High Blood Pressure)
09/01/2012 - "
Reports of 49 enquiries relating to a 'legal high' product called 'Whack' (which on analysis was found to contain 2-DPMP and fluorotropacocaine) commonly described unwanted cardiovascular (hypertension in 10/49 and tachycardia in 12/49) and neuropsychiatric (agitation in 14/49 and psychosis in 13/49) effects; the neuropsychiatric effects were prolonged, and persisted for up to 5 days.
"